IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer
January 07 2021 - 8:00AM
IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a
provider of innovative medical advancements and care specializing
in regenerative rehabilitation orthopedic treatments without the
use of surgery or opioids, today announces the appointment of Sheri
Gardzina, CPA as its Chief Financial Officer. To date, Ms. Gardzina
has served as CFO in an interim capacity.
“Sheri has been an excellent addition to our
management team since joining the company and we are pleased to
have her as our permanent Chief Financial Officer. She brings a
wealth of financial and accounting experience to the company and I
am excited to continue working with Sheri,” said Jeffrey Ervin,
Chief Executive Officer of IMAC.
Prior to joining IMAC, Ms. Gardzina served as
Chief Financial Officer of Peak Health Solutions, Inc. and Employee
Benefit Solutions, respectively. She has also served in the
capacity of chief accounting officer of Adoration Health, LLC and
was controller at SmileDirectClub, LLC and Inspiris, Inc. She began
her career as an auditor at Ernst & Young, LLP. Ms. Gardzina
earned a Bachelor of Science in business administration with a
minor in finance from Purdue University as well as a Master’s
degree in accounting and an MBA, both from Northeastern University.
She is a Certified Public Accountant. About IMAC Holdings,
Inc.
IMAC was created in March 2015 to expand on the
footprint of the original IMAC Regeneration Center, which opened in
Kentucky in August 2000. IMAC Regeneration Centers combine life
science advancements with traditional medical care for movement
restricting diseases and conditions. IMAC owns or manages 15
outpatient clinics that provide regenerative, orthopedic and
minimally invasive procedures and therapies. It has partnered with
several active and former professional athletes, opening six Ozzie
Smith IMAC Regeneration Centers, two David Price IMAC Regeneration
Centers, as well as Mike Ditka IMAC Regeneration Centers and a Tony
Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics
emphasize its focus around treating sports and orthopedic injuries
and movement-restricting diseases without surgery or opioids. More
information about IMAC Holdings, Inc. is available at
www.imacregeneration.com.
# # #
Safe Harbor Statement
This press release contains forward-looking
statements. These forward-looking statements, and terms such as
“anticipate,” “expect,” “believe,” “may,” “will,” “should” or other
comparable terms, are based largely on IMAC's expectations and are
subject to a number of risks and uncertainties, certain of which
are beyond IMAC's control. Actual results could differ materially
from these forward-looking statements as a result of, among other
factors, risks and uncertainties associated with its ability to
raise additional funding, its ability to maintain and grow its
business, variability of operating results, its ability to maintain
and enhance its brand, its development and introduction of new
products and services, the successful integration of acquired
companies, technologies and assets, marketing and other business
development initiatives, competition in the industry, general
government regulation, economic conditions, dependence on key
personnel, the ability to attract, hire and retain personnel who
possess the skills and experience necessary to meet customers’
requirements, and its ability to protect its intellectual property.
IMAC encourages you to review other factors that may affect its
future results in its registration statement and in its other
filings with the Securities and Exchange Commission. In light of
these risks and uncertainties, there can be no assurance that the
forward-looking information contained in this press release will in
fact occur.
IMAC Press Contact:
Laura Fristoe
lfristoe@imacrc.com
Investor Relations:
Bret Shapiro
(516) 222-2560
brets@coreir.com
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Sep 2023 to Sep 2024